Search - Prime Therapeutics

457 Results for GLP-1 Pipeline Update

FDA Decisions Expected: October 2025

PUBLICATIONS FDA Decisions Expected: October 2025 Your monthly synopsis of new drugs expected to hit the market September 17, 2025 Drug pipeline for October 2025 At Prime Therapeutics (Prime), we...
Metabolic dysfunction–associated steatohepatitis (MASH)

cover image for Summer 2025 Issue: Clinical Insights – MASH A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum Prime Therapeutics...

Prime Article: Research & Publications PA Research & Publications: Clinical Insights White Papers
Biosimilar basics part 2: Biosimilar naming conventions

Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.

PA Sub-Categories: Specialty drugs Prime Article: Perspectives
High-Cost Therapy Profile: September 2025

publications High-Cost Therapy Profile: September 2025 Clemidsogene Ianparvovec Intracisternal | Regenxbio / Nippon Shinyaku Metabolic-gene therapy September 22, 2025 Proposed indications ...